# Dana-Farber Cancer Institute

Dana-Farber Cancer Institute is an Endowment / Foundation based in Boston, United States.

## Overview

- **Organization type:** Endowment / Foundation
- **Headquarters:** Boston, United States
- **Region:** North America
- **Address:** 450 Brookline Avenue, Boston, MA, United States
- **Founded:** 1947
- **Assets under management:** Undisclosed
- **Website:** dana-farber.org
- **LinkedIn:** https://www.linkedin.com/company/dana-farber-cancer-institute

## Regulatory record

- **Reports private funds:** No

## About

Dana-Farber Cancer Institute in Boston, MA, is a world leader in adult and pediatric cancer treatment and research. Our oncologists and cancer researchers practice and develop some of the most advanced cancer treatments in the world.

## Sectors

- Healthcare Services
- Philanthropy

## Offices

- Chestnut Hill, MA

## People

- Josh Bekenstein — Chairman of the Board of Trustees
- Richard Lubin — Vice Chairman of the Board of Trustees
- Chris Hadley — Trustee; Chairman of the Investment Committee

## Questions

### Who runs investment decisions at Dana-Farber?

The Investment Committee is chaired by Chris Hadley, a managing director at Berkshire Partners with deep private equity experience. He is joined on the Board of Trustees by Josh Bekenstein, co-chairman of Bain Capital, and Richard Lubin, co-founder of Berkshire Partners. This governance structure places investment oversight in the hands of Boston-based private equity principals rather than traditional institutional asset managers.

### How is Dana-Farber's endowment structured compared to a university endowment?

Unlike a university endowment that supports broad academic operations, Dana-Farber's endowment serves a single-mission institution: cancer research and clinical care. The portfolio must fund fixed-cost research infrastructure — lab space, investigator salaries, clinical trial operations — while also supporting brick-and-mortar expansion like the future cancer hospital at One Joslin Place. This creates a sharper liquidity-need profile than a diversified university fund.

### How is Dana-Farber related to Harvard Medical School?

Dana-Farber is the principal teaching affiliate for oncology at Harvard Medical School. This relationship means Dana-Farber faculty hold Harvard Medical School appointments and the institute trains Harvard medical students and fellows in cancer specialization. The affiliation also ties Dana-Farber into the broader Harvard hospital ecosystem, including Brigham and Women's Hospital and Boston Children's Hospital, both clinical partners for inpatient care.

### What is the Dana-Farber/Harvard Cancer Center?

The Dana-Farber/Harvard Cancer Center (DF/HCC) is a National Cancer Institute-designated comprehensive cancer center that pools research across Harvard-affiliated hospitals including Dana-Farber, Massachusetts General Hospital, Brigham and Women's Hospital, and Boston Children's Hospital. This consortium approach allows shared clinical trial infrastructure and cross-institutional investigator teams, funded in part by NCI grants rather than endowment draw.

## Related profiles

- [Dalton Corporation, Warsaw Manufacturing Facility Pension Plan](https://altss.com/profile/dalton-corporation-warsaw-manufacturing-facility-pension-plan)
- [Danaher Corporation](https://altss.com/profile/danaher-corporation)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/dana-farber-cancer-institute

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology